---
title: 'Medicine ğŸŠâ­'
date: 2023-01-03
permalink: /note/medicine
tags:
  - note
toc: true
---

Essences of various diseases.

{% include toc %}

# Gastrointestinal / æ¶ˆåŒ–ç®¡

## Esophageal disorders / é£Ÿé“ç–¾æ‚£

## Gastric and duodenal disorders / èƒƒãƒ»åäºŒæŒ‡è…¸æ½°ç˜

## Small intestine, large intestine, and anal disorders / å°è…¸ãƒ»å¤§è…¸ãƒ»è‚›é–€ç–¾æ‚£

## Diaphragm, peritoneum, and abdominal wall disorders / æ¨ªéš”è†œãƒ»è…¹è†œãƒ»è…¹å£ç–¾æ‚£

## Liver Disorders / è‚ç–¾æ‚£

### Acute Viral Hepatitis / æ€¥æ€§ã‚¦ã‚¤ãƒ«ã‚¹æ€§è‚ç‚

* **Concept**
  * Acute inflammatory liver disease caused by an immune response to hepatitis viruses replicating within liver cells
* **Symptoms**
  * Influenza-like symptoms: General fatigue, gastrointestinal discomfort, fever, muscle pain
  * Liver symptoms: Jaundice, itching of the skin, hepatomegaly
* **Tests**
  * Blood:
    * ASTâ†‘, ALTâ†‘, Prolonged PT
    * Bilirubinâ†‘, ICG retention rateâ†‘
    * ALP and Î³-GT mildly elevated
  * Viral markers:
    * Type A: IgM-HA antibody
    * Type B: HBs antigen, IgM-HBc antibody
    * Type C: HCV-RNA
  * Abdominal ultrasound: Enlarged and reddish liver
* **Treatment**
  * Supportive therapy: Bed rest, calorie supplementation
{: .notice--info}

### Chronic Viral Hepatitis / æ…¢æ€§ã‚¦ã‚¤ãƒ«ã‚¹æ€§è‚ç‚

* **Concept**
  * Persistent inflammation of the liver due to hepatitis viruses lasting for more than 6 months
* **Symptoms**
  * Asymptomatic
* **Tests**
  * Blood:
    * ASTâ†‘, ALTâ†‘
    * Gamma-globulinâ†‘, TTT/ZTTâ†‘, hyaluronic acidâ†‘, plateletsâ†“, ICG retention rateâ†‘
  * Viral markers:
    * Type B: HBs antigen, IgG-HBc antibody, HBV-DNA
    * Type C: HCV antibody, HCV-RNA
  * Abdominal ultrasound: Irregular liver surface and striations
  * Pathology: Bridging fibrosis, piecemeal necrosis
* **Treatment**
  * Chronic hepatitis B:
    * Interferon: Peg-IFNÎ±
    * Nucleoside analogs: Entecavir, Tenofovir
  * Chronic hepatitis C:
    * Direct-acting antivirals: Glecaprevir/Pibrentasvir
{: .notice--info}

### Drug-induced liver injury / è–¬ç‰©æ€§è‚éšœå®³

* **Concept**
  * Liver damage caused by drugs
  * Classification:
    * Hepatocellular type: Acetaminophen, Halothane, Carbon tetrachloride, Isoniazid, Methyldopa, Tetracycline, Rifampicin, Methotrexate, Azathioprine
    * Cholestatic type: Cyclosporine, Chlorpromazine, Erythromycin, Anabolic steroids, Oral contraceptives, Antithyroid drugs
* **Symptoms**
  * Asymptomatic
* **Tests**
  * Blood:
    * Eosinophilsâ†‘
    * ASTâ†‘, ALTâ†‘
    * ALPâ†‘ãƒ»Î³-GTâ†‘
  * Drug sensitivity testing: Identification of the causative drug
* **Treatment**
  * Discontinuation of the causative drug
  * Medications: Glycyrrhizin, steroids, Ursodeoxycholic acid
{: .notice--info}

### Fatty Liver / è„‚è‚ªè‚

* **Concept**
  * Accumulation of fat droplets consisting of neutral fat in over one-third of hepatocytes in liver lobules
  * Causes: Alcohol, obesity, diabetes
* **Symptoms**
  * Asymptomatic
  * Heaviness or dull pain in the right upper abdomen
* **Tests**
  * Blood:
    * AST and ALT normal to elevated
    * Serum triglycerides normal to elevated, Cholinesterase elevated
  * CT: Hypodense areas
  * Ultrasound: Bright liver, increased liver-kidney contrast, decreased deep echoes
  * Pathology: Fat deposition
  * Abdominal laparoscopy: Yellowish spots
* **Treatment**
  * Addressing the underlying cause
{: .notice--info}

### Alcoholic Liver Disease / ã‚¢ãƒ«ã‚³ãƒ¼ãƒ«æ€§è‚éšœå®³

* **Concept**
  * Liver damage caused by long-term excessive alcohol consumption.
  * Pathology: Fatty liver, liver fibrosis, hepatitis, cirrhosis
* **Tests**
  * Blood:
    * AST & ALTâ†‘ (AST>ALT), Î³-GTâ†‘â†‘, IgAâ†‘
    * Advanced liver damage: plateletsâ†“, albuminâ†“, WBCâ†‘, bilirubinâ†‘, prolonged prothrombin time
  * Pathology:
    * Fatty liver: Fatty degeneration
    * Liver fibrosis: Pericellular fibrosis
    * Hepatitis: Ballooning degeneration of hepatocytes, Mallory-Denk bodies, neutrophil infiltration
    * Cirrhosis: Nodular transformation of liver lobules
  * Abdominal laparoscopy, CT, MRI: Hepatomegaly
* **Treatment**
  * Abstinence from alcohol
  * Nutritional therapy: Vitamins, intravenous fluids
  * Hepatoprotective drugs: Ursodeoxycholic acid, Glycyrrhizin
{: .notice--info}

### Non-Alcoholic Fatty Liver Disease / éã‚¢ãƒ«ã‚³ãƒ¼ãƒ«æ€§è„‚è‚ªæ€§è‚ç–¾æ‚£

* **Concept**
  * Fatty liver disorder that does not involve a history of excessive alcohol consumption
  * Classification
    * Non-alcoholic fatty liver: Characterized by fat deposition in liver cells
    * Non-alcoholic steatohepatitis: Characterized by liver cell fat degeneration and ballooning
  * Causes: Obesity, diabetes, lipid abnormalities, hypertension, metabolic syndrome
* **Symptoms**
  * Asymptomatic
  * Discomfort in the right upper abdomen
* **Tests**
  * Blood:
    * ASTãƒ»ALTâ†‘, ferritinâ†‘, HOMA-IRâ†‘ (insulin resistance)
    * Progression: Plateletsâ†“, liver fibrosis markersâ†‘	
  * Ultrasound, CT, MRI: Bright liver, increased liver-kidney contrast, reduced deep echoes
  * Pathology: Large fat droplets, inflammation, ballooning of hepatocytes, Mallory-Denk bodies, fibrosis
* **Treatment**
  * Lifestyle guidance: Correction of dietary habits, addressing physical inactivity
  * Pharmacotherapy:
    * For diabetes: Thiazolidinediones, SGLT2 inhibitors, GLP-1 agonists
    * For hypertension: ARBs, ACE inhibitors
    * For lipid abnormalities: HMG-CoA reductase inhibitors
{: .notice--info}

## Biliary system disorders / èƒ†é“ç³»ç–¾æ‚£

## Pancreatic disorders / è†µç–¾æ‚£

# Cardiovascular / å¾ªç’°å™¨

## Arrhythmia / ä¸æ•´è„ˆ

## Ischemic heart disease / è™šè¡€æ€§å¿ƒç–¾æ‚£

## Valvular heart disease / å¿ƒå¼è†œç—‡

## Congenital heart disease / å…ˆå¤©æ€§å¿ƒç–¾æ‚£

## Endocardium, myocardium, and pericardium disorders / å¿ƒå†…è†œãƒ»å¿ƒç­‹ãƒ»å¿ƒè†œç–¾æ‚£

## Arterial disorders / å‹•è„ˆç–¾æ‚£

## Venous disorders / é™è„ˆç–¾æ‚£

## Blood pressure abnormalities / è¡€åœ§ç•°å¸¸

## Cardiac tumors / å¿ƒè‡“è…«ç˜

# Metabolism and Endocrine / ä»£è¬ãƒ»å†…åˆ†æ³Œ

## Hypothalamus and pituitary disorders / è¦–åºŠä¸‹éƒ¨ãƒ»ä¸‹å‚ä½“ç–¾æ‚£

## Thyroid disorders / ç”²çŠ¶è…ºç–¾æ‚£

## Parathyroid disorders / å‰¯ç”²çŠ¶è…ºç–¾æ‚£

## Adrenal gland disorders / å‰¯è…ç–¾æ‚£

## Other endocrine disorders / ãã®ä»–ã®å†…åˆ†æ³Œç–¾æ‚£

## Carbohydrate metabolism disorders / ç³–è³ªä»£è¬ç•°å¸¸

## Lipid metabolism disorders / è„‚è³ªä»£è¬ç•°å¸¸

## Amino acid metabolism disorders / ã‚¢ãƒŸãƒé…¸ä»£è¬ç•°å¸¸

## Other metabolic disorders / ãã®ä»–ã®ä»£è¬ç•°å¸¸

## Water and electrolyte metabolism disorders / æ°´ãƒ»é›»è§£è³ªä»£è¬ç•°å¸¸

## Bone and connective tissue metabolic disorders / éª¨ãƒ»çµåˆç¹”ã®ä»£è¬æ€§ç–¾æ‚£

## Nutritional abnormalities / æ „é¤Šã®ç•°å¸¸

# Renal and Urological / è…ãƒ»æ³Œå°¿å™¨

## Glomerular Disorders / ç³¸çƒä½“ç–¾æ‚£

### Acute Glomerulonephritis / æ€¥æ€§ç³¸çƒä½“è…ç‚

* **Concept**
  * Type III allergy to Group A Streptococcus (immunocomplex deposition in the glomeruli)
  * Occurs approximately 2 weeks after preceding infections such as pharyngitis and tonsillitis
  * Common in children (3-10 years old)
  * Many cases resolve with conservative treatment
* **Symptoms**
  * Hematuria: microscopic or gross
  * Proteinuria: Nephrotic syndrome is rare
  * Hypertension: during the oliguric phase
  * Edema: periorbital
* **Tests**
  * Blood: CH50â†“, C3â†“, ASOâ†‘, ASKâ†‘
  * Urine sediment: Red blood cell casts, granular casts
  * Light microscopy: White blood cell infiltration into capillaries, swelling of endothelial cells in capillaries
  * Fluorescence: C3 deposition in the glomerular basement membrane
  * Electron microscopy: Humps on the basement membrane
* **Treatment**
  * Dietary therapy: Restriction of salt intake, low-protein diet
  * Medication therapy: Diuretics, antihypertensive drugs
{: .notice--info}

### Rapid Progressive Glomerulonephritis / æ€¥æ€§é€²è¡Œæ€§ç³¸çƒä½“è…ç‚

* **Concept**
  * Arises from necrotizing damage to the glomerular capillary walls
  * Formation of two or more cell layers in Bowman's capsule (crescents)
  * Rapid decline in kidney function
  * Classification:
    * ANCA type (Microscopic polyangiitis, Granulomatosis with polyangiitis)
    * Immune complex type
    * Anti-glomerular basement membrane antibody type (Goodpasture syndrome)
* **Symptoms**
  * Initial: Fever, general fatigue
  * Renal symptoms: Proteinuria, hematuria, edema
  * Extrarenal symptoms: Hypertension, interstitial pneumonia, pulmonary hemorrhage
* **Tests**
  * Light microscopy: Crescent formation
  * Fluorescence: Corresponding to the classification: 
    * Minimal glomerular deposition
    * Granular deposition in glomerular capillary walls
    * Linear deposition in glomerular capillary walls
  * Electron microscopy: Basement membrane rupture
* **Treatment**
  * Combination therapy: corticosteroids (pulse therapy) and immunosuppressive drugs (cyclophosphamide)
{: .notice--info}

### IgA Nephropathy / IgAè…ç—‡

* **Concept**
  * Mesangial proliferation and deposition of IgA in the mesangial area.
* **Symptoms**
  * Hematuria: Persistent microscopic or gross during colds
  * Proteinuria: Persistent or intermittent
* **Tests**
  * Blood: IgAâ†‘
  * Urine sediment: Red blood cell casts
  * Light microscopy: Mesangial proliferation
  * Fluorescence: IgA deposition in the mesangial area
  * Electron microscopy: Electron dense deposits in the mesangial area
* **Treatment**
  * Dietary therapy: Restriction of salt and protein intake
  * Medication therapy:
    * RAAS inhibitors (ACE inhibitors, ARBs)
    * Corticosteroids
    * Tonsillectomy + Steroid pulse therapy
    * Immunosuppressive drugs
    * Antiplatelet agents
    * Omega-3 fatty acids (fish oil)
{: .notice--info}

### Chronic Glomerulonephritis / æ…¢æ€§ç³¸çƒä½“è…ç‚

* **Concept**
  * Prolonged presence of proteinuria and hematuria, leading to a gradual decline in kidney function
{: .notice--info}

### Minimal Change Nephrotic Syndrome / å¾®å°å¤‰åŒ–å‹ãƒãƒ•ãƒ­ãƒ¼ã‚¼ç—‡å€™ç¾¤

* **Concept**
  * Nephrotic syndrome common in children (3-6 years old) and young adults
  * Light microscopy shows almost normal glomeruli, and electron microscopy shows loss of podocyte foot processes
* **Symptoms**
  * Edema: Sudden generalized swelling
  * Proteinuria: High levels of albuminuria, with high selectivity for urinary protein
* **Tests**
  * Blood: Albuminâ†“, LDL cholesterolâ†‘
  * Light microscopy: Nearly normal
  * Fluorescence: No deposition observed
  * Electron microscopy: Disappearance of foot processes of the glomerular epithelial cells
* **Treatment**
  * Corticosteroids
  * Diuretics: Loop diuretics, potassium-sparing diuretics
  * Protein infusion products: Used in cases of circulatory insufficiency due to hypoalbuminemia
{: .notice--info}

### Membranous Nephropathy / è†œæ€§è…ç—‡

* **Concept**
  * Nephrotic syndrome common in adults (40 years and older)
  * Characterized by thickening of the glomerular basement membrane and deposition of immune complexes on the basement membrane
  * Causes: 80% primary (idiopathic), 20% secondary to conditions such as: 
    * Malignancies (gastric cancer, colorectal cancer, lung cancer, breast cancer, lymphoma)
    * Infections (Hepatitis B, syphilis)
    * Autoimmune diseases (SLE, RA)
    * Medications (gold salts, D-penicillamine)
* **Symptoms**
  * Edema: Chronic
  * Proteinuria: Chronic
* **Tests**
  * Blood: Albuminâ†“, LDL cholesterolâ†‘
  * Light microscopy: Basement membrane thickening, spike formation on the basement membrane
  * Fluorescence: Granular deposition of IgG and C3 along the glomerular basement membrane
  * Electron microscopy: Electron dense deposits on the epithelial side of the basement membrane
* **Treatment**
  * Supportive therapy: Diuretics, antiplatelet agents
  * Drug therapy: Steroids, immunosuppressive drugs
  * Secondary cases: Treatment of the underlying condition
{: .notice--info}

### Focal Segmental Glomerulosclerosis / å·£çŠ¶åˆ†ç¯€æ€§ç³¸çƒä½“ç¡¬åŒ–ç—‡

* **Concept**
  * Nephrotic syndrome (often demonstrating steroid resistance)
  * Characterized by localized focal segmental sclerosis lesions in some glomeruli
* **Symptoms**
  * Edema: Rapid onset
  * Proteinuria: High levels of proteinuria with low selectivity for urine protein
* **Tests**
  * Blood: Albuminâ†“, LDL cholesterolâ†‘
  * Light microscopy: Focal segmental sclerosis lesions in some glomeruli
  * Fluorescence: Granular deposition of IgG and C3 in the sclerotic areas
  * Electron microscopy: Loss of podocyte foot processes
* **Treatment**
  * Steroids
  * Cyclosporine: Used in combination with steroids for cases resistant to steroids
{: .notice--info}

### Membranoproliferative Glomerulonephritis / è†œæ€§å¢—æ®–æ€§ç³¸çƒä½“è…ç‚

* **Concept**
  * Nephrotic syndrome characterized by glomerular proliferation and low complement levels
  * Causes: Primary or secondary (Hepatitis C, cryoglobulinemia, SLE).
* **Symptoms**
  * Proteinuria: High levels
  * Hematuria: Microscopic or gross
  * Edema
* **Tests**
  * Blood: CH50â†“, C3â†“, C4â†“
  * Light microscopy: Glomerular lobulation, mesangial cell proliferation, thickening of the capillary walls, duplication of the basement membrane
  * Fluorescence: Deposition of C3, IgG, IgM in capillary walls and mesangium
  * Electron microscopy: Electron dense deposits and mesangial interposition
* **Treatment**
  * Steroids: Used in combination with immunosuppressive drugs, anticoagulants, and antiplatelet agents.
  * Secondary cases: Treatment of the underlying condition.
{: .notice--info}

### Alport Syndrome / Alportç—‡å€™ç¾¤

* **Concept**
  * Hereditary progressive nephritis accompanied by sensorineural hearing loss and eye abnormalities
  * Most cases (80%) are X-linked with abnormalities in the formation of type IV collagen
* **Symptoms**
  * Nephritis: Onset with asymptomatic hematuria and proteinuria, progresses to end-stage renal failure
  * Sensorineural hearing loss: Bilateral
  * Eye abnormalities: lenticonus, cataracts
* **Tests**
  * Light microscopy: Nonspecific findings
  * Fluorescence: Abnormalities in the detection of type IV collagen alpha-5 chain
  * Electron microscopy: Changes in the glomerular basement membrane, layering of the lamina densa
* **Treatment**
  * Disease progression control: ACE inhibitors, ARBs
  * End-stage renal failure: Dialysis, transplantation
{: .notice--info}

### Thin Basement Membrane Syndrome / è‰¯æ€§å®¶æ—æ€§è¡€å°¿ç—‡å€™ç¾¤

* **Concept**
  * Familial disease characterized by asymptomatic hematuria with a favorable prognosis
* **Symptoms**
  * Hematuria: Microscopic, occasionally gross
* **Tests**
  * Electron microscopy: Thinner than normal glomerular basement membrane
{: .notice--info}

## Tubulointerstitial disorders / å°¿ç´°ç®¡ãƒ»é–“è³ªæ€§ç–¾æ‚£

## Systemic disorders and renal disorders / å…¨èº«éšœå®³ã¨è…éšœå®³

## Renal vascular disorders / è…å¾ªç’°éšœå®³

## Congenital abnormalities / å…ˆå¤©ç•°å¸¸

## Infections / æ„ŸæŸ“ç—‡

## Tumors / è…«ç˜

## Stones / çµçŸ³

## Functional disorders / æ©Ÿèƒ½éšœå®³

## Injuries / æå‚·

# Immune and Connective Tissue Diseases / å…ç–«ãƒ»è† åŸç—…

## Immunodeficiency / å…ç–«ä¸å…¨

## Allergy / ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼

## Connective tissue disease / è† åŸç—…

# Hematology / è¡€æ¶²

## Abnormalities in the red blood cell system / èµ¤è¡€çƒç³»ã®ç•°å¸¸

## Abnormalities in the white blood cell system / ç™½è¡€çƒç³»ã®ç•°å¸¸

## Abnormalities in the hemostasis and coagulation system / æ­¢è¡€ãƒ»å‡å›ºç³»ã®ç•°å¸¸

# Infectious Diseases / æ„ŸæŸ“ç—‡

## Bacterial infections / ç´°èŒæ„ŸæŸ“ç—‡

## Fungal infections / çœŸèŒæ„ŸæŸ“ç—‡

## Viral infections / ã‚¦ã‚¤ãƒ«ã‚¹æ„ŸæŸ“ç—‡

## Parasitic infections / å¯„ç”Ÿè™«æ„ŸæŸ“ç—‡

# Respiratory / å‘¼å¸å™¨

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Obstructive lung diseases / é–‰å¡æ€§è‚ºç–¾æ‚£

## Interstitial lung diseases / é–“è³ªæ€§è‚ºç–¾æ‚£

## Abnormalities of the lungs and bronchi / è‚ºãƒ»æ°—ç®¡æ”¯ã®å½¢æ…‹ç•°å¸¸

## Lung tumors / è‚ºè…«ç˜

## Immune and allergic diseases / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼æ€§ç–¾æ‚£

## Pulmonary vascular disorders / è‚ºå¾ªç’°éšœå®³

## Functional respiratory disorders / æ©Ÿèƒ½çš„å‘¼å¸éšœå®³

## Mediastinal disorders / ç¸¦éš”ç–¾æ‚£

## Pleural and chest wall disorders / èƒ¸è†œãƒ»èƒ¸å£ç–¾æ‚£

## Breast disorders / ä¹³è…ºç–¾æ‚£

# Neurology / ç¥çµŒ

## Cerebrovascular disorders / è„³è¡€ç®¡ç–¾æ‚£

## Dementia disorders / èªçŸ¥ç—‡æ€§ç–¾æ‚£

## Demyelinating disorders / è„±é«„æ€§ç–¾æ‚£

## Degenerative disorders / å¤‰æ€§ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Muscle disorders / ç­‹ç–¾æ‚£

## Peripheral nerve disorders / æœ«æ¢¢ç¥çµŒç–¾æ‚£

## Functional seizure disorders / æ©Ÿèƒ½æ€§ç™ºä½œæ€§ç–¾æ‚£

## Neurocutaneous syndromes / æ¯æ–‘ç—‡

## Brain tumors / è„³è…«ç˜

## Head injuries / é ­éƒ¨å¤–å‚·

## Malformations / å¥‡å½¢

# Pediatrics / å°å…ç§‘

## Neonates / æ–°ç”Ÿå…

## Congenital abnormalities / å…ˆå¤©ç•°å¸¸

## Gastrointestinal disorders / æ¶ˆåŒ–å™¨ç–¾æ‚£

## Cardiovascular disorders / å¾ªç’°å™¨ç–¾æ‚£

## Metabolic and endocrine disorders / ä»£è¬ãƒ»å†…åˆ†æ³Œç–¾æ‚£

## Renal and urological disorders / è…ãƒ»æ³Œå°¿å™¨ç–¾æ‚£

## Immune and allergic disorders / å…ç–«ãƒ»ã‚¢ãƒ¬ãƒ«ã‚®ãƒ¼ç–¾æ‚£

## Hematological and hematopoietic disorders / è¡€æ¶²ãƒ»é€ è¡€å™¨ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“ç—‡

## Respiratory disorders / å‘¼å¸å™¨ç–¾æ‚£

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Tumors / è…«ç˜

# Gynecology / å©¦äººç§‘

## Menstrual abnormalities / æœˆçµŒã®ç•°å¸¸

## Abnormalities in sexual differentiation and genital morphology / æ€§åˆ†åŒ–ã¨æ€§å™¨å½¢æ…‹ã®ç•°å¸¸

## Genital inflammation and sexually transmitted infections / æ€§å™¨ã®ç‚ç—‡ãƒ»æ€§æ„ŸæŸ“ç—‡

## Infertility / ä¸å¦Š

## Age-related changes / åŠ é½¢ã«ä¼´ã†å¤‰åŒ–

## Benign tumors, pre-cancerous lesions, and neoplasms / é¡è…«ç˜ç—…å¤‰ãƒ»å‰ç™Œç—…å¤‰ãƒ»è…«ç˜

## Breast disorders / ä¹³è…ºç–¾æ‚£

# Obstetrics / ç”£ç§‘

## Abnormalities in pregnancy / å¦Šå¨ ã®ç•°å¸¸

## Complicated pregnancies and mother-child infections / åˆä½µç—‡å¦Šå¨ ãƒ»æ¯å­æ„ŸæŸ“

## Abnormalities in childbirth / åˆ†å¨©ã®ç•°å¸¸

## Postpartum period / ç”£è¤¥

# Ophthalmology / çœ¼ç§‘

## Refractive and accommodative abnormalities / å±ˆæŠ˜ãƒ»èª¿ç¯€ç•°å¸¸

## Eyelid and lacrimal system disorders / çœ¼ç¼ãƒ»æ¶™å™¨ç–¾æ‚£

## Conjunctival, corneal, and scleral disorders / çµè†œãƒ»è§’è†œãƒ»å¼·è†œç–¾æ‚£

## Uveal disorders / ã¶ã©ã†è†œç–¾æ‚£

## Retinal and vitreous disorders / ç¶²è†œãƒ»ç¡å­ä½“ç–¾æ‚£

## Optic nerve disorders / è¦–ç¥çµŒç–¾æ‚£

## Lens disorders / æ°´æ™¶ä½“ç–¾æ‚£

## Glaucoma / ç·‘å†…éšœ

## Ocular trauma / çœ¼å¤–å‚·

# Otorhinolaryngology / è€³é¼»å’½å–‰ç§‘

## Inner ear disorders / å†…è€³ç–¾æ‚£

## Middle ear disorders / ä¸­è€³ç–¾æ‚£

## Outer ear disorders / å¤–è€³ç–¾æ‚£

## Neurological disorders / ç¥çµŒç–¾æ‚£

## Nasal and sinus disorders / é¼»è…”ãƒ»å‰¯é¼»è…”ç–¾æ‚£

## Oral, tonsil, and salivary gland disorders / å£è…”ãƒ»æ‰æ¡ƒãƒ»å”¾æ¶²è…ºç–¾æ‚£

## Pharyngeal and laryngeal disorders / å’½é ­ãƒ»å–‰é ­ç–¾æ‚£

# Orthopedics / æ•´å½¢å¤–ç§‘

## Fractures / éª¨æŠ˜

## Dislocations / è„±è‡¼

## Spinal cord and spinal disorders / è„Šæ¤ãƒ»è„Šé«„ç–¾æ‚£

## Upper limb disorders / ä¸Šè‚¢ã®ç–¾æ‚£

## Lower limb disorders / ä¸‹è‚¢ã®ç–¾æ‚£

## Infectious diseases / æ„ŸæŸ“æ€§ç–¾æ‚£

## Peripheral nerve injuries / æœ«æ¢¢ç¥çµŒæå‚·

## Metabolic bone disorders / ä»£è¬æ€§éª¨ç–¾æ‚£

## Tumors / è…«ç˜

# Psychiatry / ç²¾ç¥ç§‘

## Neurotic disorders / ç¥çµŒç—‡æ€§éšœå®³

## Mood disorders and schizophrenia / æ°—åˆ†éšœå®³ãƒ»çµ±åˆå¤±èª¿ç—‡

## Substance-related disorders / ç‰©è³ªé–¢é€£éšœå®³

## Physiological disorders / ç”Ÿç†çš„éšœå®³

## Neurodevelopmental disorders / ç¥çµŒç™ºé”ç—‡ç¾¤

# Dermatology / çš®è†šç§‘

## Eczema and dermatitis group / æ¹¿ç–¹ãƒ»çš®è†šç‚ç¾¤

## Urticaria and itching group / è•éº»ç–¹ãƒ»æ»ç—’ç¾¤

## Erythema / ç´…æ–‘ç—‡

## Bullous diseases / æ°´ç–±ç—‡

## Pustular diseases / è†¿ç–±ç—‡

## Pigmentation disorders / è‰²ç´ ç•°å¸¸ç—‡

## Nevus / æ¯æ–‘ç—‡

## Keratosis disorders / è§’åŒ–ç•°å¸¸

## Benign tumors / è‰¯æ€§è…«ç˜

## Malignant tumors / æ‚ªæ€§è…«ç˜

## Metabolic disorders / ä»£è¬ç•°å¸¸

# Urology / æ³Œå°¿å™¨ç§‘

## Congenital abnormalities / å…ˆå¤©ç•°å¸¸

## Tumors / è…«ç˜

## Male genital disorders / ç”·æ€§å™¨ç–¾æ‚£